Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |